Abstract
Hurthle cell changes are frequently seen in reactive/hyperplastic conditions and can be extensive, resulting in the formation of nodules that must be distinguished from their neoplastic counterparts, Hurthle cell adenomas and Hurthle cell carcinoma. The primary goal of thyroid FNA in the management of Hurthle cell nodules is to separate those for which surgery is indicated, i.e., Hurthle cell adenomas and carcinomas, from those that can be managed conservatively, i.e., adenomatous nodules with oncocytic changes and Hashimoto’s thyroiditis. The distinction between Hurthle cell adenomas and carcinomas is not possible on cytology because of the inability of cytology to establish the presence of capsular and/or vascular invasion. Therefore, rendering a diagnosis of Hurthle cell neoplasm implies that these lesions should be excised to exclude a malignancy. The criteria for diagnosing “follicular neoplasm, Hurthle cell type,” or “suspicious for a follicular neoplasm, Hurthle cell type” are moderately to markedly cellular aspirate that consists exclusively or predominantly (>75 %) of Hurthle cells with little or no colloid and lack of background lymphocytes. The Hurthle cells can be either small with high N/C ratio (≥50 %) (small cell dysplasia) or large with at least 2× variability in nuclear size (large cell dysplasia). The differential diagnosis includes other neoplasms such as oncocytic and tall cell variants of papillary thyroid carcinoma, medullary carcinoma, parathyroid adenoma, and metastatic renal cell carcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press; 2004.
Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology. New York, NY: Springer; 2010.
Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF. Invasive Hürthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc. 1984;59:851–5.
Renshaw AA. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer. 2002;96:261–6.
Wu HH, Clouse J, Ren R. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid. Diagn Cytopathol. 2008;36:149–54.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Adeniran, A.J., Chhieng, D. (2016). Hürthle Cell Lesions. In: Common Diagnostic Pitfalls in Thyroid Cytopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-31602-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-31602-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-31600-0
Online ISBN: 978-3-319-31602-4
eBook Packages: MedicineMedicine (R0)